Federal Judge Upholds Medicare's Drug Price Negotiation Program, Ruling For Patients And Rejecting Pharmaceutical Industry Lawsuit.
Oral arguments were presented today in the case brought by Boehringer Ingelheim Pharmaceuticals challenging Medicare’s authority to negotiate lower drug prices for patients.
The ongoing legal assault on Medicare negotiation continues as AstraZeneca has filed a notice to appeal a federal judge’s ruling against the company’s lawsuit to overturn the program.
Federal Court Rejects Big Pharma’s "Strongest Arguments" Challenging Constitutionality of Medicare Negotiation Program, Marking Another Win For Patients
Patients For Affordable Drugs Launches New Website Aimed At Defending Medicare Negotiation
Patients For Affordable Drugs Continues to Fight Against Big Pharma's Attempts to Undermine Medicare Drug Price Negotiation As Some Of The Largest Drug Companies Have Their Day In Court
Patients For Affordable Drugs Responds to Judge's Ruling Against AstraZeneca in The Pharmaceutical Corporation’s Lawsuit Against Medicare Drug Price Negotiation
Patients For Affordable Drugs Continues Fight Against Big Pharma's Attempts To Undermine Medicare Drug Price Negotiation In Landmark Case: AstraZeneca Pharmaceuticals LP et al. v. Becerra et al.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
